G

Genprex
D

GNPX

0.27570
USD
0.01
(4.04%)
مغلق
حجم التداول
811
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
7,670,287
أصول ذات صلة
G
GNFT
0.09000
(2.13%)
4.32000 USD
G
GNSS
-0.05500
(-3.23%)
1.65000 USD
المزيد
الأخبار المقالات

العنوان: Genprex

القطاع: Healthcare
الصناعة: Biotechnology
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for largepatient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.